A Phase 1, First-in-human, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Intravenous Dose Study of a novel TREM2 agonist (VGL101) in Healthy Volunteers (HVs) (S14.004)

Autor:	Spyridon Papapetropoulos, Andreas Meier, Ryan O'Mara, Andrew Marsh, Kelly Neelon, Rajasimhan Rajagovindan, Evan Thackaberry, David Stiles
Rok vydání:	2023
Zdroj:	Monday, April 24.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c29c0e684e025d4724ea7e7c14ad7f27 https://doi.org/10.1212/wnl.0000000000203636 Zobrazit plný text záznamu